Nav: Home

Europe sees constant increase in gonorrhoea infections

May 31, 2016

Since 2008, the overall rate of reported gonorrhoea infections has more than doubled across Europe, going up from 8 per 100 000 population to 20 cases per 100 000 persons in 2014.

In total, 66 413 gonorrhoea cases were reported in 27 countries of the European Union and European Economic Area (EU/EEA) in 2014 - which constitutes an increase of 25% compared with 2013. The highest rates were observed in the United Kingdom (60 per 100 000), Ireland (28), Denmark (20) and Latvia (18). The majority of gonorrhoea infections were diagnosed among young adults aged 15-24 years who accounted for 38% of cases; followed by the 25-34-year-olds (34%).

Looking at ways of transmission, almost half (44%) of the reported gonorrhoea diagnoses in the EU/EEA in 2014 were reported to be among men who have sex with men (MSM). This is only slightly lower than the proportion of male and female heterosexuals combined (49%).

Rise in gonorrhoea cases among women

In 2014, for the first time since ECDC started collecting this data (2010), the number of cases among women was higher than the number of cases among heterosexual men.

Given the risk of reproductive tract complications, e.g. pelvic inflammatory disease or, if untreated, infertility, as well as possible transmission from mother to child, this trend among women is of particular concern.

A threat for treatment success: drug-resistant gonococci

The European treatment guidelines for gonorrhoea recommend use of two antimicrobials (ceftriaxone or cefixime together with azithromycin). The latest resistance data from the European Gonococcal Antimicrobial Surveillance Programme suggest stable levels of drug resistance to cefixime, and no significant increase in resistance to another key drug (ceftriaxone).

Resistance to azithromycin, however, appears to be increasing and the effectiveness of this recommended dual treatment might be under threat if resistance to third-generation cephalosporins (cefixime and ceftriaxone) also starts to increase again. As the control of gonorrhoea depends on effective antimicrobial treatment, even a small increase in drug resistance has a huge impact due to the risk of treatment failure.

The rising trend in the number of reported of gonorrhoea cases points at on-going condomless sex that also heightens the risk of transmission of other sexually transmitted infections, including HIV (11% of those infected with gonorrhoea were co-infected with HIV). The increasing number of cases among MSM highlight the need to further strengthen prevention activities which target specific groups by using effective, evidence-based messages and methods.
See also: ECDC Surveillance Atlas of infectious Diseases: gonorrhoea

European Centre for Disease Prevention and Control (ECDC)

Related Drug Resistance Articles:

Cause of drug resistance in a drug resistance in intestinal tumors identified
Researchers clarify mechanisms that allow hard-to-treat cancers to develop, and have identified strategies that could lead to new therapies.
Engineered viruses could fight drug resistance
MIT biological engineers can program bacteriophages to kill different strains of E. coli by making mutations in the protein that the viruses use to bind to host cells.
Origin of resistance to lung-cancer drug discovered
Researchers at Kanazawa University report in Nature Communications what causes some lung-cancer patients to have an intrinsic resistance to the drug osimertinib: AXL, a protein belonging to the class of receptor tyrosine kinases.
New drug resistance process found in bacteria
Researchers at the UAB and the UMBC have described a new process capable of generating resistance to synthetic antibacterial drugs within bacterial populations long before their invention and without the existence of any similar substance in nature.
Alzheimer's drug may help battle antibiotic resistance
Dangerous antibiotic-resistant bacteria could soon be targeted with a drug initially developed to treat Alzheimer's disease.
New drug candidates reverse drug resistance in multiple myeloma in preclinical models
A new strategy to enhance the activity of proteasome inhibitors (PIs), which are standard-of-care agents in the treatment of multiple myeloma (MM), was reported by researchers at the Medical University of South Carolina in the journal Leukemia.
Testing cells for cancer drug resistance
Biophysicists at Ruhr-Universit├Ąt Bochum (RUB) have demonstrated that Raman microscopy can be used to detect the resistance of tumour cells to cancer drugs.
Flu virus could evolve resistance to pandemic drug
The influenza virus can evolve resistance to an anti-flu drug currently in development for use in pandemics but only if there are multiple genetic mutations, a study has found.
Drug-resistance of gonorrhoea in the EU: persistent but stable
Neisseria gonorrhoea continues to show high levels of resistance to azithromycin across the European Union and European Economic Area, according to the 2016 results of the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP).
Keeping cancer out of breath blocks drug resistance
Chemists have demonstrated a new approach to blocking cancer-drug resistance that they believe could be applied to any type of cancer.
More Drug Resistance News and Drug Resistance Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.